Denk-Air Junior 5mg tablets chewable

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

montelukast (montelukast sodium)

Available from:

Denk Pharma GmbH & Co. KG

ATC code:

R03DC03

INN (International Name):

montelukast (montelukast sodium)

Dosage:

5mg

Pharmaceutical form:

tablets chewable

Units in package:

(28/2x14/) In blister

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2017-06-22

Patient Information leaflet

_Denk-Air Junior 5 mg_
For children 6 to 14 years of age
Chewable tablet – oral use
Leukotriene receptor antagonist
Active substance: montelukast
PACKAGE LEAFLET:
INFORMATION FOR THE USER
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU/YOUR CHILD START/STARTS TAKING THIS MEDI-
CINE BECAUSE IT CONTAINS IMPORTANT INFORMA-
TION FOR YOU.
– Keep this leaflet. You may need to read it
again.
– If you have any further questions, ask your
doctor or pharmacist.
– This medicine has been prescribed for
you/your child only. Do not pass it on to oth-
ers. It may harm them, even if their signs of
illness are the same as yours/your child’s.
– If any of the side effects gets serious, talk to
your doctor or pharmacist. This includes any
possible side effects not listed in this leaflet.
See section 4.
WHAT IS IN THIS LEAFLET
1. WHAT DENK-AIR JUNIOR 5 MG IS AND
WHAT IT IS USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU USE
DENK-AIR JUNIOR 5 MG
3. HOW TO USE DENK-AIR JUNIOR 5 MG
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE DENK-AIR JUNIOR 5 MG
6. CONTENTS OF THE PACK AND OTHER INFORMATION
1.
WHAT DENK-AIR JUNIOR 5 MG IS
AND WHAT IT IS USED FOR
Denk-Air Junior 5 mg is a medicine that blocks the
binding of certain inflammatory mediators
(leukotrienes). Leukotrienes cause narrowing and
swelling of the airways in the lungs. By blocking the
leukotrienes, Denk-Air Junior 5 mg alleviates the
symptoms of asthma, and helps to control asthma.
The doctor has prescribed Denk-Air Junior 5 mg for
you/your child so as to prevent symptoms of
asthma occurring during the day and night.
– Denk-Air Junior 5 mg is used in patients whose
asthma symptoms could not be adequately con-
trolled by previous medication and who require
an additional treatment.
– Denk-Air Junior 5 mg can also be used in children
6 to 14 years of age instead of inhalations con-
taining cortisone (inhaled corticosteroids), under
the following circumstances:
• if there have been no recent, severe asthma
attacks which have required treatment with
cortisone tablets.
• if the